Toxoplasmosis in Cats: Zoonotic Transmission and Public Health Concerns
By Dr. Zubair Khalid, DVM, MS, PhD ·
Key Takeaways
- Toxoplasma gondii, an obligate intracellular apicomplexan parasite, utilizes felids as definitive hosts for its sexual reproductive cycle, exclusively shedding environmentally resistant oocysts in feces. Transmission to intermediate hosts, including humans, occurs via ingestion of sporulated oocysts or tissue cysts.
- Most immunocompetent cats remain asymptomatic, but clinical signs can manifest as ocular (uveitis, chorioretinitis), neurological (ataxia, seizures), respiratory, hepatic, pancreatic, or cardiac pathology, particularly in immunocompromised individuals or kittens.
- Diagnosis relies on a combination of serological tests (IFAT, ELISA for IgM/IgG), molecular detection (PCR for T. gondii DNA in blood, CSF, or feces), and histopathology with immunohistochemistry to identify tachyzoites or tissue cysts.
- Zoonotic transmission to humans is primarily through ingestion of contaminated food or water, or handling contaminated cat litter, posing significant risks for congenital toxoplasmosis, ocular disease, and neurological complications in immunocompromised individuals.
- Control strategies include keeping cats indoors, feeding commercially processed or cooked food, daily cleaning of litter boxes to prevent oocyst sporulation, and meticulous hygiene practices, especially for pregnant women and immunocompromised individuals.
- Treatment for symptomatic cats typically involves clindamycin (10-12 mg/kg PO q12h for 2-4 weeks), with supportive care as needed; however, treatment does not eradicate tissue cysts, and cats remain chronically infected.
Etiology
Toxoplasmosis is caused by the obligate intracellular apicomplexan parasite Toxoplasma gondii. This protozoan parasite has a complex life cycle that involves felids as the definitive host and many warm-blooded animals, including humans, as intermediate hosts [<a href="#ref-1">1</a>, <a href="#ref-2">2</a>]. The parasite exists in three principal infectious stages: tachyzoites (rapidly dividing forms), bradyzoites (slowly dividing forms contained within tissue cysts), and sporozoites (contained within sporulated oocysts) [<a href="#ref-3">3</a>, <a href="#ref-4">4</a>]. The tachyzoite stage is responsible for acute infection and dissemination, while bradyzoites establish chronic infection in tissues such as skeletal muscle, cardiac muscle, and neural tissue [<a href="#ref-5">5</a>, <a href="#ref-6">6</a>]. The oocyst stage, which is shed exclusively in the feces of felids, is the environmentally resistant form that facilitates transmission to intermediate hosts [<a href="#ref-7">7</a>, <a href="#ref-8">8</a>].
Life Cycle and Definitive Host Biology
The sexual phase of the T. gondii life cycle occurs exclusively within the intestinal epithelium of felids, making cats the only definitive host [<a href="#ref-9">9</a>, <a href="#ref-10">10</a>]. A single-cell atlas of T. gondii sexual development in the feline intestinal tract has elucidated the transcriptional programs governing the transition from asexual to sexual stages [<a href="#ref-11">11</a>]. After ingestion of tissue cysts (bradyzoites) from infected prey, the bradyzoites are released in the feline small intestine and invade enterocytes, where they undergo multiple rounds of asexual replication (schizogony) followed by gametogony and oocyst formation [<a href="#ref-10">10</a>, <a href="#ref-11">11</a>]. The pre-sexual stages exhibit a distinct mode of cell division characterized by endodyogeny, a process in which two daughter cells are formed within the mother cell [<a href="#ref-10">10</a>]. The dynamic landscape of microRNA expression in the feline small intestine during T. gondii infection has been characterized, revealing host microRNA responses that may modulate parasite replication and immune evasion [<a href="#ref-12">12</a>].
Unsporulated oocysts are shed in the feces, a process that typically begins 3 to 10 days after primary infection and can last for 1 to 3 weeks [<a href="#ref-13">13</a>, <a href="#ref-14">14</a>]. A single infected cat can shed millions of oocysts per day [<a href="#ref-14">14</a>]. After shedding, oocysts require 1 to 5 days of exposure to oxygen and appropriate temperature and humidity to sporulate and become infectious [<a href="#ref-7">7</a>, <a href="#ref-8">8</a>]. Sporulated oocysts are highly resistant to environmental degradation and can remain viable in soil, water, and on surfaces for months to years [<a href="#ref-1">1</a>, <a href="#ref-15">15</a>].
Epidemiology and Seroprevalence
Seroprevalence of T. gondii in domestic cat populations varies widely by geographic region, management practices, and lifestyle. A study in Hong Kong reported seroprevalence rates of 27.3% in privately-owned cats and 37.8% in community cats, with demographic factors such as age and outdoor access significantly associated with seropositivity [<a href="#ref-13">13</a>]. In Jordan, seroprevalence in cats was found to be 41.2% using serological methods, with molecular detection of T. gondii DNA in fecal samples confirming active shedding in a subset of animals [<a href="#ref-16">16</a>]. A study in Bangkok, Thailand, detected T. gondii DNA in 8.3% of fecal samples from stray cats, indicating ongoing environmental contamination [<a href="#ref-14">14</a>]. Seroprevalence in veterinary medicine professionals and students in Mexico was reported at 18.5%, highlighting occupational exposure risks [<a href="#ref-6">6</a>].
The parasite also infects a broad range of intermediate hosts, including livestock and wildlife. Seroprevalence in goats from Nigeria was reported at 34.7%, with risk factors including age, breed, and management system [<a href="#ref-15">15</a>]. In dairy cattle in Turkey, seroprevalence was 12.4% [<a href="#ref-17">17</a>]. In pigs from eastern Spain, seroprevalence was low at 2.1% in intensive farms with controlled animal entry [<a href="#ref-18">18</a>]. In deer from Iraq, seroprevalence was 15.6% [<a href="#ref-19">19</a>]. In dogs from the Pantanal region of Brazil, seroprevalence was 54.2% for T. gondii [<a href="#ref-20">20</a>]. These data underscore the widespread distribution of T. gondii in animal populations and the potential for zoonotic transmission.
Clinical Signs in Cats
Most immunocompetent cats infected with T. gondii remain asymptomatic [<a href="#ref-16">16</a>, <a href="#ref-21">21</a>]. Clinical disease, when it occurs, is most commonly observed in kittens, immunocompromised adults, or cats with concurrent infections [<a href="#ref-22">22</a>]. The clinical presentation depends on the organ systems affected. Ocular toxoplasmosis can present as uveitis, chorioretinitis, or anterior chamber inflammation [<a href="#ref-23">23</a>]. Neurological signs, including ataxia, seizures, circling, and behavioral changes, are associated with cat toxoplasmosis brain involvement, where tachyzoites cause focal or multifocal necrotizing encephalitis [<a href="#ref-24">24</a>, <a href="#ref-25">25</a>]. A study of 72 cats with pyogranulomatous and neutrophilic lymphadenitis identified toxoplasmosis as a differential diagnosis in a subset of cases [<a href="#ref-22">22</a>]. Respiratory signs, including dyspnea and cough, can result from pneumonitis. Hepatic and pancreatic involvement may lead to icterus and vomiting. Myocarditis can cause arrhythmias and congestive heart failure.
Pathology
The pathological hallmark of acute toxoplasmosis is multifocal necrosis with a mixed inflammatory infiltrate composed of neutrophils, macrophages, and lymphocytes [<a href="#ref-22">22</a>, <a href="#ref-26">26</a>]. In the brain, lesions consist of necrotic foci with microglial nodules, perivascular cuffing, and the presence of free tachyzoites or tissue cysts [<a href="#ref-24">24</a>, <a href="#ref-25">25</a>]. In the lungs, interstitial pneumonia with alveolar edema and fibrin exudation is observed. In the liver, multifocal necrotizing hepatitis is common. Tissue cysts containing bradyzoites are found in skeletal muscle, cardiac muscle, and the central nervous system, and these cysts can persist for the life of the host without eliciting significant inflammation [<a href="#ref-5">5</a>, <a href="#ref-6">6</a>].
Diagnostics
Diagnosis of feline toxoplasmosis relies on a combination of serological, molecular, and histopathological methods.
Serological Testing
Serological detection of anti-T. gondii antibodies is the most common diagnostic approach. The indirect fluorescent antibody test (IFAT) and enzyme-linked immunosorbent assays (ELISA) are widely used to detect IgM and IgG antibodies [<a href="#ref-2">2</a>, <a href="#ref-9">9</a>]. A double-antigen sandwich colloidal gold immunochromatographic strip has been developed and validated for detection of T. gondii antibodies in multiple host species, including cats, offering a rapid point-of-care option [<a href="#ref-2">2</a>]. A SAG1-based colloidal gold immunochromatographic strip has also been developed for serological detection in swine, with potential cross-species applicability [<a href="#ref-9">9</a>]. The MIC17A antigen has been evaluated as a marker for both entero-epithelial and chronic stage infection in feline toxoplasmosis [<a href="#ref-21">21</a>]. The AB blood group system phenotype does not play a role in T. gondii infection in cats [<a href="#ref-27">27</a>].
Molecular Detection
Polymerase chain reaction (PCR) assays targeting the B1 gene or the 529 bp repeat element are highly sensitive and specific for detection of T. gondii DNA in blood, aqueous humor, cerebrospinal fluid, and tissue samples [<a href="#ref-14">14</a>, <a href="#ref-16">16</a>, <a href="#ref-28">28</a>]. An antisense PCR assay has been developed and evaluated for detection of T. gondii in domestic cats, demonstrating improved sensitivity compared to conventional PCR [<a href="#ref-28">28</a>]. PCR detection of T. gondii DNA in fecal samples is used to identify actively shedding cats, although the sensitivity is limited by intermittent shedding and the presence of PCR inhibitors in feces [<a href="#ref-14">14</a>].
Histopathology and Cytology
Histopathological examination of biopsy or necropsy tissues can reveal characteristic lesions and the presence of tachyzoites or tissue cysts [<a href="#ref-22">22</a>, <a href="#ref-26">26</a>]. Immunohistochemistry using anti-T. gondii antibodies can confirm the presence of the parasite in tissue sections. Cytological examination of cerebrospinal fluid, bronchoalveolar lavage fluid, or fine-needle aspirates may reveal tachyzoites in acute cases.
Diagnostic Workflow
graph TD
A["Clinical Suspicion of Feline Toxoplasmosis"] --> B{"Serological Testing"}
B --> C["IgM and IgG ELISA/IFAT"]
C --> D{"IgM Positive, IgG Negative or Low"}
D --> E["Acute or Recent Infection"]
C --> F{"IgG Positive, IgM Negative"}
F --> G["Chronic or Past Infection"]
C --> H{"Both IgM and IgG Positive"}
H --> I["Active or Reactivated Infection"]
B --> J["PCR on Blood, CSF, or Aqueous Humor"]
J --> K{"Positive"}
K --> L["Confirm Active Infection"]
J --> M{"Negative"}
M --> N["Does Not Rule Out Infection"]
B --> O["Fecal PCR or Microscopy"]
O --> P{"Positive"}
P --> Q["Active Oocyst Shedding"]
O --> R{"Negative"}
R --> S["Does Not Rule Out Shedding"]
B --> T["Histopathology with IHC"]
T --> U["Definitive Diagnosis on Tissue"]Treatment
Treatment is indicated for cats with clinical signs of toxoplasmosis. The standard therapeutic regimen consists of clindamycin administered at 10 to 12 mg/kg orally every 12 hours for 2 to 4 weeks [<a href="#ref-22">22</a>]. Alternative therapies include trimethoprim-sulfonamide combinations or pyrimethamine combined with a sulfonamide. Supportive care, including fluid therapy, nutritional support, and anti-inflammatory doses of corticosteroids for ocular or neurological inflammation, may be necessary. Treatment does not eliminate tissue cysts, and cats remain chronically infected [<a href="#ref-3">3</a>, <a href="#ref-8">8</a>].
Control and Prevention
Control of toxoplasmosis in cats focuses on reducing exposure to the parasite and preventing environmental contamination. Cats should be kept indoors to prevent hunting of infected prey [<a href="#ref-13">13</a>, <a href="#ref-16">16</a>]. Feeding only commercially processed or cooked food eliminates the risk of ingesting tissue cysts [<a href="#ref-15">15</a>, <a href="#ref-18">18</a>]. Litter boxes should be cleaned daily, as oocysts require 1 to 5 days to sporulate and become infectious [<a href="#ref-7">7</a>, <a href="#ref-8">8</a>]. Pregnant women and immunocompromised individuals should avoid handling cat litter or should wear disposable gloves and wash hands thoroughly after cleaning [<a href="#ref-29">29</a>, <a href="#ref-30">30</a>].
Zoonotic Transmission and Public Health Concerns
Zoonotic transmission of T. gondii occurs primarily through ingestion of sporulated oocysts from contaminated environments or ingestion of tissue cysts in undercooked meat [<a href="#ref-1">1</a>, <a href="#ref-15">15</a>, <a href="#ref-31">31</a>]. Toxoplasmosis in cat poop represents a major public health concern, as oocysts shed by cats can contaminate soil, water, and food sources [<a href="#ref-14">14</a>, <a href="#ref-16">16</a>]. Oocysts can be transported via runoff into water supplies and can persist in the environment for extended periods [<a href="#ref-1">1</a>, <a href="#ref-15">15</a>].
Human infection can also occur through congenital transmission from an infected mother to the fetus, which can result in miscarriage, stillbirth, or congenital toxoplasmosis with neurological and ocular sequelae [<a href="#ref-5">5</a>, <a href="#ref-7">7</a>, <a href="#ref-29">29</a>]. A study in Turkey found anti-T. gondii antibody seropositivity in 38.5% of women with a history of abortion or stillbirth [<a href="#ref-5">5</a>]. In Côte d'Ivoire, knowledge and practices towards toxoplasmosis among pregnant women were found to be inadequate, highlighting the need for public health education [<a href="#ref-7">7</a>].
The parasite has been associated with a range of human health outcomes beyond congenital infection. Cerebral toxoplasmosis is a serious complication in immunocompromised individuals, such as organ transplant recipients [<a href="#ref-24">24</a>]. Ocular toxoplasmosis can cause vision impairment and is a leading cause of posterior uveitis worldwide [<a href="#ref-23">23</a>]. The association between T. gondii seropositivity and neuropsychiatric conditions, including psychotic experiences and changes in grey matter volume, has been investigated in population-based cohort studies [<a href="#ref-25">25</a>]. The parasite's ability to alter host behavior has been documented in both animal models and human studies [<a href="#ref-32">32</a>].
Seroprevalence in human populations varies widely. In sickle cell disease patients, seroprevalence was 45.5%, with blood transfusion history identified as a risk factor [<a href="#ref-31">31</a>]. In quilombola communities in Brazil, seroprevalence was 68.2%, with risk factors including age, contact with soil, and consumption of raw meat [<a href="#ref-30">30</a>]. Social marginalisation and environmental degradation have been linked to increased T. gondii exposure in urban informal settlements in Brazil [<a href="#ref-1">1</a>].
Vaccine Development
Significant research efforts are directed towards developing vaccines against T. gondii for both veterinary and human use. Gene-edited live-attenuated vaccines have shown promise in preclinical studies, with targeted deletion of virulence genes resulting in strains that induce protective immunity without causing disease [<a href="#ref-3">3</a>]. Advances in antigen discovery and mRNA vaccine platforms are being explored under a One Health framework [<a href="#ref-8">8</a>]. The MIC17A antigen has been identified as a potential vaccine candidate due to its expression in both entero-epithelial and chronic stages [<a href="#ref-21">21</a>].